Literature DB >> 14344117

[A MEDULLOBLASTOMA WITH TRANSVERSELY STRIATED MUSCLE FIBERS].

J W BOELLAARD.   

Abstract

Entities:  

Keywords:  CEREBELLAR NEOPLASMS; CHILD; MEDULLOBLASTOMA

Mesh：

Year:  1964        PMID： 14344117

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr        ISSN： 0003-9373


× No keyword cloud information.
  3 in total

1.  A CASE OF MEDULLOMYOBLASTOMA.

Authors:  P J BOFIN; E EBELS
Journal:  Acta Neuropathol       Date:  1963-02-11       Impact factor: 17.088

2.  [ON A MEDULLOBLASTOMA WITH GIANT CELLS].

Authors:  T TZONOS; C V BRUNNGRABER
Journal:  Zentralbl Neurochir       Date:  1963

3.  Rhabdomyosarcoma of cerebellum.

Authors:  J LOPES DE FARIA
Journal:  AMA Arch Pathol       Date:  1957-03
  3 in total
  6 in total

1.  Cerebellar medullomyoblastoma with advanced neuronal differentiation and hamartomatous component.

Authors:  T Höll; P Kleihues; M G Yasargil; O D Wiestler
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Primary rhabdomyosarcoma of the central nervous system.

Authors:  B Pasquier; P Couderc; D Pasquier; P M Hong; J Pellat
Journal:  Acta Neuropathol       Date:  1975-12-30       Impact factor: 17.088

3.  Primary intracranial rhabdomyosarcoma producing proptosis.

Authors:  S Shuangshoti; C Phonprasert
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-06       Impact factor: 10.154

4.  Fine structure of myomedulloblastoma.

Authors:  R Stahlberger; R L Friede
Journal:  Acta Neuropathol       Date:  1977-01-31       Impact factor: 17.088

5.  Medullomyoblastoma: report of two cases.

Authors:  D Schiffer; M T Giordana; S Pezzotta; T Pezzulo; M C Vigliani
Journal:  Childs Nerv Syst       Date:  1992-08       Impact factor: 1.475

6.  The role of immunohistochemistry in medullomyoblastoma--a case series highlighting divergent differentiation.

Authors:  Man Updesh S Sachdeva; Mahesha Vankalakunti; Aruna Rangan; Bishan D Radotra; Rajesh Chhabra; Rakesh K Vasishta
Journal:  Diagn Pathol       Date:  2008-04-25       Impact factor: 2.644
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.